Bioe Calm while Breastfeeding

What is Bioe Calm used for?

Is Bioe Calm usage safe while breastfeeding? If a lactating mother is using it can there be any effect on growth or development of infant?

Aconitum napellus root while Breastfeeding

The flowers and roots and leaves of this herbaceous plant are used. It contains sesquiterpene lactones, essential oil, flavonoids and traces of pyrrolizidine alkaloids. Topical use on whole skin. Indications in traditional medicine without evidence of its effectiveness: topical anti-inflammatory in bruises, sprains and localized muscle pain (EMA 2014). Do not apply to damaged skin It is very toxic orally (Anderson 2017), having described gastroenteritis, cardiac arrhythmia, neurological problems and death (WHO 2007 p.77, nal 2001) in people who took it and a case of severe hemolytic anemia in 9-day-old newborn whose mother was taking arnica infusion (Miller 2009). At the date of the last update, we did not find published data on its excretion in breast milk. The small dose and poor plasma absorption of most topical dermatological preparations make it unlikely that a significant amount will pass into breast milk. Do not apply on the breast so that the infant does not ingest it, or in large areas or for prolonged periods to avoid systemic absorption. Hands should be washed after applying arnica to avoid possible contact with the infants mouth.

Arsenic trioxide while Breastfeeding

Used in the treatment of promyelocitic leukemia in adults.

Activated charcoal while Breastfeeding

CAS Number: 7440-44-0

Powdered carbon with high adsorption levels.Administrated orally, it adsorbs drugs and toxins, avoiding their absorption from the gastrointestinal tract. It also has uses as an antidiarrheal and antiflatulent and for marking breast lesions in mammography. Since the last update we have not found published data about its excretion in breast milk. Its zero intestinal absorption (Torbet 2005, AEMPS 1998) prevents its passing into plasma and therefore into breast milk. It use is permitted in infants under one year old (Pediamecum 2015).

Strychnos ignatii seed while Breastfeeding

CAS Number: 8046-97-7

Dried seed of this plant has been used. It contains brucine and strychnine. It is highly toxic and easily lethal.

Lithium carbonate while Breastfeeding

CAS Number: 554-13-2

It is excreted into breast milk in amounts that may be clinically significant and can be as high as a half of that reached in mother’s plasma and up to one third of the therapeutic level in the infant. In infants and newborns (5 days), premature babies and dehydrated or infected infants, who may show reduced clearance mechanisms for lithium, there have been reports of clear signs of lithium toxicity caused by ingestion of breast milk: cyanosis, lethargy, hypotonia or slight increase in TSH. However, there are numerous cases of infants whose mothers were on lithium who did not show any clinical, growth or neurodevelopmental problem at the short or long term. Breastfeeding is less risky for healthy term infants whose mothers are treated with lithium when she or her family has capacity enough to monitor the occurrence of adverse effects, medical supervision and, whenever necessary, monitoring of lithium levels in the mother-infant dyad. Mothers should stop taking lithium 1 to 2 days before delivery or cesarean section in order to decrease plasma levels in the newborn. Lithium may be, or not, a cause of increased Prolactin and galactorrhea.

Sodium chloride while Breastfeeding

CAS Number: 7647-14-5

Sodium chloride either as cooking salt, or, as oral rehydration solution, or, as IV fluid, is entirely compatible with BF.

Strychnos nux-vomica seed while Breastfeeding

CAS Number: 8046-97-7

Dried seed of this plant has been used. It contains brucine and strychnine. It is highly toxic and easily lethal.

Lead while Breastfeeding

CAS Number: 7439-92-1

It is an environmental contaminant. As a heavy metal it is found in excess in products like paintings, fuel and metal industry. Certain make-ups, infusion herbals, meat from chased animals and ceramic made pottery may increase the risk of exposure. It can be stored in soft tissues for one month and in bones for decades. Removing of lead from bones occurs during pregnancy and lactation leading to an increase in the serum many years after exposure. It can cause cardiovascular and respiratory toxicity. More intensively it affects infants and children it may cause neurologic damage. Maximal accepted levels by international agencies like WHO, CDC, EFSA – even though a 0 level is desirable – are: 10 mcg/L in water, 5 mcg/L in breast milk and an ingestion of 2.5 mcg/k/d for infants less of 6 months of age. Absorption through the lungs is 50% and through the gut is less than 10%. In blood of unexposed persons serum levels should not be higher than 10 mcg/dL. Working mothers at fertile age showing a lead serum level higher than 30 mcg/dL should be removed from work place. Working pregnant or nursing women should be removed from places with high risk of toxin exposition (Regulated by EU Council Law/85/ from 19.10.1992). Mothers should not breastfeed if they are found to be intoxicated or contaminated. Same recommendation is suitable for mothers who undergo a chelating treatment (since lead is removed from bones and let free). Blood and breast milk testing is highly recommended to have lead level measured. Mothers should avoid nursing whenever lead level is higher than 16 mcg/L in the milk or 16 mcg/dL in the serum. (Lead levels in the milk are usually 10% of those in the serum). Benefits of breastfeeding widely overcome those issues related to the presence of low level environmental contaminants in human milk that in many instances are lower than those present in cow’s milk based products and other food. (Codex alimentarius FAO-WHO). Published papers from studies done on this matter have shown higher lead levels contained in powdered artificial milks than in human milk.

Valerian while Breastfeeding

CAS Number: 8057-49-6

At last update significant data on breastfeeding were not found. A commonly used herb in many cultures and countries, even during pregnancy and breastfeeding with very few reported side-effects. Whenever not abused it has a low toxicity. Moderate use is considered to be compatible with breastfeeding, however because of the possibility of sedative effect in infants should better be avoided in cases of prematurity and in the neonatal period. Be aware of sedative effects in the infant. Roots, rhizomes and stolons of the plant are used. It contains iridoids, valepotriates, steroids, essential oils, GABA and tannins. Unproven beneficial effects in adults: sedative, hypnotic, anti-spasmodic. Indication after Commission E of German Ministry of Health: insomnia, nervousness, anxiety. Maximal daily dose: 9 g (2 g of dried extract)

Arsenic trioxide while Breastfeeding

CAS Number: 1327-53-3

Most sources consider breastfeeding to be contraindicated during maternal antineoplastic drug therapy. It might be possible to breastfeed safely during intermittent therapy with an appropriate period of breastfeeding abstinence; the manufacturer recommends an abstinence period of 1 week after the last dose. Chemotherapy may adversely affect the normal microbiome and chemical makeup of breastmilk.[1] Women who receive chemotherapy during pregnancy are more likely to have difficulty nursing their infant.[2]

Lithium carbonate while Breastfeeding

CAS Number: 554-13-2

Although lithium appears on many lists of drugs contraindicated during breastfeeding, other sources do not consider it an absolute contraindication, especially in infants over 2 months of age and during lithium monotherapy.[1][2][3][4] Numerous reports exist of infants who were breastfed during maternal lithium therapy without any signs of toxicity or developmental problems. Most were breastfed from birth and some continued to nurse for up to 1 year of maternal lithium therapy. Limited data suggest that lithium in milk can adversely affect the infant when its elimination is impaired, as in dehydration or in newborn or premature infants. Neonates may also have transplacentally acquired serum lithium levels. Because maternal lithium requirements and dosage may be increased during pregnancy, maternal serum levels should be monitored frequently postpartum and dosage reduced as necessary to avoid excessive infant exposure via breastmilk.[5] The long-term effects of lithium on infants are not certain, but limited data indicate no obvious problems in growth and development.[6] Lithium may be used in mothers of fullterm infants who are willing and able to monitor their infants. Discontinuing lithium 24 to 48 hours before Cesarean section delivery or at the onset of spontaneous labor and resuming the prepregnancy lithium dose immediately after delivery should minimize the infant's serum lithium concentration at birth.[7] Some investigators recommend monitoring infant serum lithium, serum creatinine, BUN, and TSH in intervals ranging from "periodic" to every 4 to 12 weeks during breastfeeding and maternal lithium therapy.[3][8][9] However, others recommend close pediatric follow-up of the infant and only selective laboratory monitoring as clinically indicated.[7] Breastfeeding should be discontinued immediately and the infant evaluated if the infant appears restless or lethargic or has feeding problems.[7]

Valerian while Breastfeeding

CAS Number: 8008-88-6; 8057-49-6

Valerian (Valeriana officinalis) root contains mono- and sesquiterpenes, and iridoid triesters (valepotriates). Preparations are sometimes standardized on valerenic acid content. Valerian has no specific uses in nursing mothers, but is most commonly used to treat anxiety and sleep disturbances, and occasionally for self-treatment of postpartum blues or depression.[1][2] No data exist on the safety and efficacy of valerian in nursing mothers or infants. In general, valerian is well tolerated, with side effects such as dizziness, hangover or headache reported occasionally. Valerian is "generally recognized as safe" (GRAS) for use in food by the U.S. Food and Drug Administration. Valerian is often not recommended during lactation because of the theoretical concerns over its valepotriates and baldrinals which have been shown to be cytotoxic and mutagenic in vitro. Because there is no published experience with valerian during breastfeeding, an alternate therapy may be preferred, especially while nursing a newborn or preterm infant. Dietary supplements do not require extensive pre-marketing approval from the U.S. Food and Drug Administration. Manufacturers are responsible to ensure the safety, but do not need to the safety and effectiveness of dietary supplements before they are marketed. Dietary supplements may contain multiple ingredients, and differences are often found between labeled and actual ingredients or their amounts. A manufacturer may contract with an independent organization to verify the quality of a product or its ingredients, but that does certify the safety or effectiveness of a product. Because of the above issues, clinical testing results on one product may not be applicable to other products. More detailed information #about dietary supplements# is available elsewhere on the LactMed Web site.

Sepia officinalis juice and Breastfeeding

SEPIA OFFICINALIS is usually low in mercury and its likely safe in breastfeeding.

Thuja occidentalis leafy twig and Breastfeeding

Thuja is one of the most common remedies used for warts. Topical Usage of Thuja for wart is likely safe while breastfeeding. We do not have sufficient safety usage data for Thuja oral consumption, However its likely unsafe to use thuja orally while breastfeeding.

What should I do if I am breastfeeding mother and I am already exposed to Bioe Calm?

I am nursing mother and my doctor has suggested me to use Bioe Calm, is it safe?

If I am using Bioe Calm, will my baby need extra monitoring?

Who can I talk to if I have questions about usage of Bioe Calm in breastfeeding?